Susan S. Jick, DSc
Boston University School of Public Health
Dept of Epidemiology

DSc, Boston University
MPH, Boston University

Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.

A Postmarketing Surveillance Study of Otezla
11/01/2015 - 12/29/2017 (PI)
Celgene Corporation

Iodinated contrast agents and risk of hypothyroidism in young children in the United States
04/29/2016 - 10/31/2017 (PI)
Bayer AG

Maternal depression and antidepressant use during pregnancy and risk of childhood autism spectrum disorders in offspring
09/01/2015 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development

Study of patients with rare disease
05/27/2016 - 05/26/2017 (PI)
EpiSource, LLC Genzyme Corporation

Longitudinal Study of Morbidity and Mortality in Primary Vasculitis
03/01/2015 - 02/28/2017 (PI)
Vasculitis Foundation

Prevalence of hypercalcemia of malignancy (HCM) among cancer patients (C14-018)
02/14/2014 - 12/31/2016 (PI)
Amgen, Inc.

Persistent Side-Effects of 5-Alpha-Reductase Inhibitor Treatment
09/01/2014 - 07/31/2016 (PI)
New England Research Institutes NIH NIDDK

Incidence, prevalence and treatment patterns of pediatric pulmonary hypertension in the US
09/21/2015 - 03/31/2016 (PI)
Bayer AG

A study to estimate the prevalence of diabetic nephropathy in a pediatric United States population
12/19/2014 - 06/30/2015 (PI)
Bayer AG

Epidemiology of Giant Cell Tumor of the Bone in the UK - Phase II (C13-135)
12/01/2013 - 04/30/2015 (PI)
Amgen, Inc.

Showing 10 of 14 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Becker C, Jick SS, Meier CR. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis. Ophthalmology. 2017 May 29. PMID: 28571893.
  2. Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of Incident Antidepressant-Treated Depression Associated with Use of 5a-Reductase Inhibitors Compared with Use of a-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink. Pharmacotherapy. 2017 May; 37(5):517-527. PMID: 28295443; DOI: 10.1002/phar.1925;.
  3. Becker C, Jick SS, Meier CR, Bodmer M. Metformin and the risk of renal cell carcinoma: a case-control analysis. Eur J Cancer Prev. 2017 May; 26(3):257-262. PMID: 26945286; DOI: 10.1097/CEJ.0000000000000246;.
  4. Meier CR, Jick SS. Antenatal Exposure and Diseases in the Offspring: The Role of Big Data. Drug Saf. 2017 May; 40(5):363-364. PMID: 28185070; DOI: 10.1007/s40264-017-0514-5;.
  5. Li L, Neogi T, Jick S. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford). 2017 May 01; 56(5):753-762.View Related Profiles. PMID: 28077689; DOI: 10.1093/rheumatology/kew482;.
  6. Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. J Invest Dermatol. 2017 Jun; 137(6):1240-1247. PMID: 28202399; DOI: 10.1016/j.jid.2017.01.031;.
  7. Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS. Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. Clin Epidemiol. 2017; 9:83-91. PMID: 28228662; DOI: 10.2147/CLEP.S124674;.
  8. Frey N, Hügle T, Jick SS, Meier CR, Spoendlin J. Hyperlipidaemia and incident osteoarthritis of the hand: a population-based case-control study. Osteoarthritis Cartilage. 2017 Jul; 25(7):1040-1045. PMID: 28189828; DOI: 10.1016/j.joca.2017.01.014;.
  9. Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF. Metabolic syndrome in relation to risk of meningioma. Oncotarget. 2017 Jan 10; 8(2):2284-2292. PMID: 27903988; DOI: 10.18632/oncotarget.13667;.
  10. Spoendlin J, Layton JB, Mundkur M, Meier C, Jick SS, Meier CR. The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Saf. 2016 Dec; 39(12):1229-1237. PMID: 27677637.
Showing 10 of 254 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 254 publications over 32 distinct years, with a maximum of 27 publications in 2016

Contact for Mentoring:

11 Muzzey St
Lexington MA 02421
Google Map

Jick's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department